title: The design of clinical trials for new therapies in bladder cancer. Is it time for new strategies?
authors.affiliation: St. Radboud Ziekenhuis, Nijmegen, The Netherlands.
authors.forename: P H
authors.initials: PH
authors.lastname: De Mulder
authors.forename: R
authors.initials: R
authors.lastname: Williams
authors.forename: Y
authors.initials: Y
authors.lastname: Ohashi
authors.forename: B A
authors.initials: BA
authors.lastname: Blumenstein
authors.forename: M
authors.initials: M
authors.lastname: De Pauw
authors.forename: J
authors.initials: J
authors.lastname: Kumazawa
authors.forename: K
authors.initials: K
authors.lastname: Obata
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
authors.forename: D
authors.initials: D
authors.lastname: Tolley
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D012107:Research Design; D001749:Urinary Bladder Neoplasms / Q000628:therapy*